▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1324 by analyst upside · 2026-09-27
SRZN
Surrozen, Inc.
Healthcare · Market Cap $347M · P/E 0x
ANALYST PRICE TARGET
+63.8%
implied upside to consensus target
Current Price $29.54
Consensus Target $48.4
Bull Target $54.0
Bear Target $40.0
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
5
Hold
0
Sell
0
52-Week Low $11.39
52-Week High $37.83
YTD Return +37.1%
FUNDAMENTALS
Market Cap $347M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-40.06
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $12M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $11.39
52-Week High $37.83
Current Price $29.54
Bear Target $40.0
Bull Target $54.0
● Now $29.54 ● Target $48.4
TRADING DATA
Avg Volume 391K
YTD Return +37.1%
Analyst Count 5
Consensus Buy
Upside to Target +63.8%
Last Updated 2026-09-27

ANALYST SUMMARY

Surrozen, Inc. (SRZN) is currently trading at $29.54 with a Wall Street consensus price target of $48.4, implying potential upside of 63.8% over the next 12 months. 5 analysts currently cover SRZN, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $54.0, while the most cautious has a target of $40.0.

SRZN operates in the Healthcare sector with a market capitalisation of $347M. The stock is up 37.1% year-to-date and is currently trading near the upper end of its 52-week range of $11.39 – $37.83.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SRZN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. - Reiterated
Buy → Buy 2026-09-25 31% win rate (48 calls)
William Blair ● Initiated
Outperform 2026-08-20 44% win rate (9 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-08-10 31% win rate (48 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-05-07 31% win rate (48 calls)
TD Cowen ● Initiated
Buy 2026-04-21 Building track record
Cantor Fitzgerald reit
Overweight → Overweight 2026-03-24 40% win rate (10 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-03-24 31% win rate (48 calls)
Cantor Fitzgerald ● Initiated
Overweight 2026-02-19 40% win rate (10 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
62
out of 100
Coverage depth
14/30
Consensus clarity
21/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →